UPDATE: Market bears resurface, S&P 500 balks -2-
UPDATE: Market bears resurface, S&P 500 balks at the breakdown point
Emerging Molecular Diagnostic Technologies and Strategic Profiles of Leading Suppliers 2017 - Research and Markets
Bull trend intact, S&P 500 survives second -2-
Bull trend intact, S&P 500 survives second test of 50-day average
Global Emerging Cancer Diagnostics (Tumor Biomarker Test) Market Analysis & Forecast 2017-2023: Focus on Biomarker Test Type, Application & Market Trends - Research and Markets
UPDATE: S&P 500 survives test of 50-day -2-
UPDATE: S&P 500 survives test of 50-day average amid technical cross currents
With the first half of 2005 in the rearview mirror, it's time for another review of how the stock star rating is doing. I'm happy to report that after lagging a bit in the first quarter, we've now pulled ahead of most of our benchmarks. The First Half of 2005 As a reminder, we measure our ...
With 2004 in the rearview mirror, I thought I'd share another Morningstar Rating for stocks performance review with you. Our results continue to be positive, which makes this a pleasant review to write. As before, we're measuring ourselves by creating a hypothetical portfolio that buys 5-star ...